These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

180 related articles for article (PubMed ID: 33775244)

  • 1. Septic shock due to Escherichia coli meningoencephalitis treated with immunoglobulin-M-enriched immunoglobulin preparation as adjuvant therapy: a case report.
    Pota V; Passavanti MB; Coppolino F; Di Zazzo F; De Nardis L; Esposito R; Fiore M; Mangoni di Santostefano GSRC; Aurilio C; Sansone P; Pace MC
    J Med Case Rep; 2021 Mar; 15(1):138. PubMed ID: 33775244
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Severe sepsis and septic shock by Escherichia coli, clinical and microbiological analysis in Medellin, Colombia].
    Restrepo-Álvarez CA; Bernal E; Ascuntar-Tello J; Jaimes F
    Rev Chilena Infectol; 2019 Aug; 36(4):447-454. PubMed ID: 31859768
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Septic shock from descending necrotizing mediastinitis - combined treatment with IgM-enriched immunoglobulin preparation and direct polymyxin B hemoperfusion: a case report.
    Pota V; Passavanti MB; Sansone P; Pace MC; Peluso F; Fiorelli A; Aurilio C
    J Med Case Rep; 2018 Mar; 12(1):55. PubMed ID: 29499757
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Antimicrobial resistance patterns, clinical features, and risk factors for septic shock and death of nosocomial E coli bacteremia in adult patients with hematological disease: A monocenter retrospective study in China.
    Ma J; Li N; Liu Y; Wang C; Liu X; Chen S; Xie X; Gan S; Wang M; Cao W; Wang F; Liu Y; Wan D; Sun L; Sun H
    Medicine (Baltimore); 2017 May; 96(21):e6959. PubMed ID: 28538389
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Impact of appropriate antimicrobial therapy for patients with severe sepsis and septic shock--a quality improvement study.
    Yokota PK; Marra AR; Martino MD; Victor ES; Durão MS; Edmond MB; dos Santos OF
    PLoS One; 2014; 9(11):e104475. PubMed ID: 25375775
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Polyvalent immunoglobulin significantly attenuated the formation of IL-1β in Escherichia coli-induced sepsis in pigs.
    Barratt-Due A; Sokolov A; Gustavsen A; Hellerud BC; Egge K; Pischke SE; Lindstad JK; Pharo A; Castellheim A; Thorgersen EB; Mollnes TE
    Immunobiology; 2013 May; 218(5):683-9. PubMed ID: 22947599
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Escherichia coli urosepsis complicated with myocarditis mimicking acute myocardial infarction.
    Chen TC; Lu PL; Lin CY; Lin WR; Chen YH
    Am J Med Sci; 2010 Oct; 340(4):332-4. PubMed ID: 20601856
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Cost-effectiveness of immunoglobulin M-enriched immunoglobulin (Pentaglobin) in the treatment of severe sepsis and septic shock.
    Neilson AR; Burchardi H; Schneider H
    J Crit Care; 2005 Sep; 20(3):239-49. PubMed ID: 16253792
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Community-acquired Escherichia coli meningoencephalitis in an adult--case report].
    Kepa L; Oczko-Grzesik B; Woźnica I; Wilczek K
    Przegl Epidemiol; 2008; 62(3):565-9. PubMed ID: 19108520
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Comparison between non-septic and septic cases in stone-related obstructive acute pyelonephritis and risk factors for septic shock: A multi-center retrospective study.
    Yamamichi F; Shigemura K; Kitagawa K; Fujisawa M
    J Infect Chemother; 2018 Nov; 24(11):902-906. PubMed ID: 30174285
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Outcomes and risk factors for mortality in community-onset bacteremia caused by extended-spectrum beta-lactamase-producing Escherichia coli, with a special emphasis on antimicrobial therapy.
    Kang CI; Wi YM; Ko KS; Chung DR; Peck KR; Lee NY; Song JH
    Scand J Infect Dis; 2013 Jul; 45(7):519-25. PubMed ID: 23509913
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Mortality in Patients With Septic Shock by Multidrug Resistant Bacteria: Risk Factors and Impact of Sepsis Treatments.
    Busani S; Serafini G; Mantovani E; Venturelli C; Giannella M; Viale P; Mussini C; Cossarizza A; Girardis M
    J Intensive Care Med; 2019 Jan; 34(1):48-54. PubMed ID: 28100110
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Listeria monocytogenes and Escherichia coli septicemia and meningoencephalitis in a 7-day-old llama.
    Frank N; Couëtil LL; Clarke KA
    Can Vet J; 1998 Feb; 39(2):100-2. PubMed ID: 10051957
    [TBL] [Abstract][Full Text] [Related]  

  • 14. IgMA-enriched immunoglobulin in neutropenic patients with sepsis syndrome and septic shock: a randomized, controlled, multiple-center trial.
    Hentrich M; Fehnle K; Ostermann H; Kienast J; Cornely O; Salat C; Ubelacker R; Buchheidt D; Behre G; Hiddemann W; Schiel X
    Crit Care Med; 2006 May; 34(5):1319-25. PubMed ID: 16540956
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [The effect of pentaglobin therapy on prognosis in patients with severe sepsis].
    Tuğrul S; Ozcan PE; Akinci O; Cağatay A; Cakar N; Esen F
    Ulus Travma Derg; 2001 Oct; 7(4):219-23. PubMed ID: 11705075
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Clinical experience with polyclonal IgM-enriched immunoglobulins in a group of patients affected by sepsis after cardiac surgery.
    Buda S; Riefolo A; Biscione R; Goretti E; Cattabriga I; Grillone G; Bacchi-Reggiani L; Pacini D
    J Cardiothorac Vasc Anesth; 2005 Aug; 19(4):440-5. PubMed ID: 16085247
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Megalocytic interstitial nephritis following acute pyelonephritis with Escherichia coli bacteremia: a case report.
    Kwon HJ; Yoo KH; Kim IY; Lee S; Jang HR; Kwon GY
    J Korean Med Sci; 2015 Jan; 30(1):110-4. PubMed ID: 25552891
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Comparative Genomics of
    Ranjan A; Shaik S; Nandanwar N; Hussain A; Tiwari SK; Semmler T; Jadhav S; Wieler LH; Alam M; Colwell RR; Ahmed N
    mBio; 2017 Aug; 8(4):. PubMed ID: 28811343
    [No Abstract]   [Full Text] [Related]  

  • 19. Clinical features and outcomes of community-acquired late-onset sepsis: Focusing on group B Streptococcus and Escherichia coli.
    Yun KW; Park SH; Cho EY; Lee H
    Pediatr Int; 2019 Dec; 61(12):1210-1215. PubMed ID: 31560155
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Treatment of gram-negative septic shock with human IgG antibody to Escherichia coli J5: a prospective, double-blind, randomized trial.
    Calandra T; Glauser MP; Schellekens J; Verhoef J
    J Infect Dis; 1988 Aug; 158(2):312-9. PubMed ID: 3136210
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.